Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (News)

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 DocWire News Featured Reading 18 February 2022 https://www.docwirenews.com/abstracts/repurposing-low-dose-naltrexone-ldn-for-the-prevention-and-treatment-of-immunothrombosis-in-covid-19/ Coronavirus disease 2019 (COVID-19) is characterized by striking dysregulation of the immune system, with evidence of hyperinflammation, an impaired induction of interferons, and delayed adaptive immune responses. In addition to dysfunctional immune responses, thrombosis […]

VIDEO: Low-dose naltrexone shows promise in two patients with ‘complex’ refractory Crohn’s (News)

VIDEO: Low-dose naltrexone shows promise in two patients with ‘complex’ refractory Crohn’s Healio Gastroenterology 15 February 2022 https://www.healio.com/news/gastroenterology/20220215/video-lowdose-naltrexone-shows-promise-in-two-patients-with-complex-refractory-crohns Though further study is warranted, Leonard B. Weinstock, MD, FACP, gastroenterology specialist at the Washington University School of Medicine, reported promising results of low-dose naltrexone use among two patients with Crohn’s disease. “This is a medication that […]